Safety and tolerability of virucidal hand rubs: a randomized, double-blind, cross-over trial

por Conrad, A, Cosic, D, Schmoor, C, Dettenkofer, M
Publicado 2011

Modelling the effects of standard prognostic factors in node-positive breast cancer

por Sauerbrei, W, Royston, P, Bojar, H, Schmoor, C, Schumacher, M
Publicado 1999

Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from...

por Berger, C, Bertz, H, Schmoor, C, Behringer, D, Potthoff, K, Mertelsmann, R, Finke, J
Publicado 1999

Addressing COVID-19 challenges in a randomised controlled trial on exercise interventions in a high-risk population

por Kienle, G. S., Werthmann, P., Grotejohann, B., Hundhammer, T., Schmoor, C., Stumpe, Ch, Voigt-Radloff, S., Huber, R.
Publicado 2021

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

por Harder, J, Ihorst, G, Heinemann, V, Hofheinz, R, Moehler, M, Buechler, P, Kloeppel, G, Röcken, C, Bitzer, M, Boeck, S, Endlicher, E, Reinacher-Schick, A, Schmoor, C, Geissler, M
Publicado 2012

Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF

por Colleoni, M, Litman, H J, Castiglione-Gertsch, M, Sauerbrei, W, Gelber, R D, Bonetti, M, Coates, A S, Schumacher, M, Bastert, G, Rudenstam, C-M, Schmoor, C, Lindtner, J, Collins, J, Thürlimann, B, Holmberg, S B, Crivellari, D, Beyerle, C, Neumann, R L A, Goldhirsch, A
Publicado 2002